SUBSCRIBE
SUBSCRIBE
News   Deals

Solvay Chemicals Inc. Sells Caprolactones Unit for 200 Million Euros

October 15, 2007 | 
1 min read
BRUSSELS, Oct 15 (Reuters) - Belgian drugs, chemicals and plastics maker Solvay (SOLB.BR: Quote, Profile, Research) said on Monday it had sold its Caprolactones business for 200 million euros ($284.3 million) to Sweden's Perstorp Group.
Mergers & acquisitions Europe
MORE ON THIS TOPIC
Close the deal by shaking hands. Art collage. Orange circle in the center.
Obesity
Novo Doubles Down on Oral Obesity Meds With Septerna Deal Worth up to $2.4B
May 14, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
Hands reach out to each other. Handshake. Halftone retro hands. Body parts cut out of newspaper. Hands tied with thread. Shaking hands. Make a deal. Successful agreement. Modern collage
Drug discovery
AbbVie Dives Further Into siRNA With $335M Upfront in ADARx Deal
May 14, 2025
 · 
2 min read
 · 
Annalee Armstrong
Art 3d banner collage of business people dollar roll cooperation success payment capital profit transaction money corruption.
MASH
GSK Buys Phase III–Ready Liver Drug in Potential $2B Deal To Play in MASH Arena
May 14, 2025
 · 
2 min read
 · 
Tristan Manalac
Businessman on a crossroad. Man choosing career. Searching of right path. Decision and brainstorming concept. Flat vector illustration.
C-suite
Galapagos Takes Dramatic U-Turn, Ditching Spinout Plan, Cell Therapy and CEO Stoffels
May 13, 2025
 · 
2 min read
 · 
Annalee Armstrong